Pharmacia & Upjohn Rogaine sales grow 7% to $31 mil., Nicorette up 30% to $52 mil..
This article was originally published in The Tan Sheet
Executive Summary
PHARMACIA & UPJOHN ROGAINE SALES GROW 6.6% TO $30.9 MIL. in the first quarter, boosted by the U.S. introduction of OTC Rogaine Extra Strength for men (5% minoxidil), the company announced April 29. P&U launched the extra strength topical hair regrowth solution on New Year's Day ("The Tan Sheet" Jan. 5, p. 13). Rogaine Extra Strength has been spared the loss of exclusivity protection of regular Rogaine (2% minoxidil), which did not obtain Waxman/Hatch market exclusivity and was quickly joined by branded and private label competitors after its launch.
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning